309 related articles for article (PubMed ID: 36850057)
1. Reflections on the Lack of Consideration of Ethnic Ancestry to Stratify Clozapine Dosing.
de Leon J
Psychiatry Investig; 2023 Mar; 20(3):183-195. PubMed ID: 36850057
[TBL] [Abstract][Full Text] [Related]
2. An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels.
de Leon J; Schoretsanitis G; Smith RL; Molden E; Solismaa A; Seppälä N; Kopeček M; Švancer P; Olmos I; Ricciardi C; Iglesias-Garcia C; Iglesias-Alonso A; Spina E; Ruan CJ; Wang CY; Wang G; Tang YL; Lin SK; Lane HY; Kim YS; Kim SH; Rajkumar AP; González-Esquivel DF; Jung-Cook H; Baptista T; Rohde C; Nielsen J; Verdoux H; Quiles C; Sanz EJ; De Las Cuevas C; Cohen D; Schulte PFJ; Ertuğrul A; Anıl Yağcıoğlu AE; Chopra N; McCollum B; Shelton C; Cotes RO; Kaithi AR; Kane JM; Farooq S; Ng CH; Bilbily J; Hiemke C; López-Jaramillo C; McGrane I; Lana F; Eap CB; Arrojo-Romero M; Rădulescu FŞ; Seifritz E; Every-Palmer S; Bousman CA; Bebawi E; Bhattacharya R; Kelly DL; Otsuka Y; Lazary J; Torres R; Yecora A; Motuca M; Chan SKW; Zolezzi M; Ouanes S; De Berardis D; Grover S; Procyshyn RM; Adebayo RA; Kirilochev OO; Soloviev A; Fountoulakis KN; Wilkowska A; Cubała WJ; Ayub M; Silva A; Bonelli RM; Villagrán-Moreno JM; Crespo-Facorro B; Temmingh H; Decloedt E; Pedro MR; Takeuchi H; Tsukahara M; Gründer G; Sagud M; Celofiga A; Ignjatovic Ristic D; Ortiz BB; Elkis H; Pacheco Palha AJ; LLerena A; Fernandez-Egea E; Siskind D; Weizman A; Masmoudi R; Mohd Saffian S; Leung JG; Buckley PF; Marder SR; Citrome L; Freudenreich O; Correll CU; Müller DJ
Pharmacopsychiatry; 2022 Mar; 55(2):73-86. PubMed ID: 34911124
[TBL] [Abstract][Full Text] [Related]
3. Do Asian Patients Require Only Half of the Clozapine Dose Prescribed for Caucasians? A Critical Overview.
de Leon J; Rajkumar AP; Kaithi AR; Schoretsanitis G; Kane JM; Wang CY; Tang YL; Lin SK; Hong KS; Farooq S; Ng CH; Ruan CJ; Andrade C
Indian J Psychol Med; 2020; 42(1):4-10. PubMed ID: 31997860
[TBL] [Abstract][Full Text] [Related]
4. Can Slow Personalized Titration Using C-Reactive Protein Monitoring Decrease the High Rates and Mortality of Clozapine-Associated Myocarditis Seen in Some Countries? A Call for Research.
de Leon J
J Clin Psychopharmacol; 2024 May-Jun 01; 44(3):212-219. PubMed ID: 38595145
[TBL] [Abstract][Full Text] [Related]
5. Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition.
Schoretsanitis G; Anıl Yağcıoğlu AE; Ruan CJ; Eap CB; Molden E; Baptista T; Clark SR; Fernandez-Egea E; Kim SH; Lane HY; Leung J; Maroñas Amigo O; Motuca M; Olmos I; Every-Palmer S; Procyshyn RM; Rohde C; Satish S; Schulte PFJ; Spina E; Takeuchi H; Verdoux H; Correll CU; de Leon J
Schizophr Res; 2024 Jun; 268():302-307. PubMed ID: 37268453
[TBL] [Abstract][Full Text] [Related]
6. An international guideline with six personalised titration schedules for preventing myocarditis and pneumonia associated with clozapine.
de Leon J; Ruan CJ; Schoretsanitis G; Rohde C; Yağcıoğlu EA; Baptista T; Kirilochev OO; De Las Cuevas C; Correll CU
Gen Psychiatr; 2022; 35(3):e100773. PubMed ID: 35866000
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacogenomics of clozapine in an ancestrally diverse sample: a longitudinal analysis and genome-wide association study using UK clinical monitoring data.
Pardiñas AF; Kappel DB; Roberts M; Tipple F; Shitomi-Jones LM; King A; Jansen J; Helthuis M; Owen MJ; O'Donovan MC; Walters JTR
Lancet Psychiatry; 2023 Mar; 10(3):209-219. PubMed ID: 36804072
[TBL] [Abstract][Full Text] [Related]
8. Should we routinely add CRP to clozapine titrations? - Learning from three cases.
Shelton C; Ruan CJ; Ertuğrul A; Cotes RO; De Leon J
Neuropsychopharmacol Hung; 2022 Dec; 24(4):153-161. PubMed ID: 36775960
[TBL] [Abstract][Full Text] [Related]
9. Using therapeutic drug monitoring to personalize clozapine dosing in Asians.
de Leon J; Schoretsanitis G; Kane JM; Ruan CJ
Asia Pac Psychiatry; 2020 Jun; 12(2):e12384. PubMed ID: 32119764
[TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
11. Reflections on the Complex History of the Concept of Clozapine-Induced Inflammation during Titration.
de Leon J
Psychiatr Danub; 2022; 34(3):411-421. PubMed ID: 36256975
[TBL] [Abstract][Full Text] [Related]
12. Four cases of myocarditis in US hospitals possibly associated with clozapine poor metabolism and a comparison with prior published cases.
Koenig M; McCollum B; Spivey JK; Coleman JK; Shelton C; Cotes RO; Goldsmith DR; De Leon J
Neuropsychopharmacol Hung; 2022 Mar; 24(1):29-41. PubMed ID: 35451590
[TBL] [Abstract][Full Text] [Related]
13. A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology.
de Leon J; Ruan CJ; Schoretsanitis G; De Las Cuevas C
Psychother Psychosom; 2020; 89(4):200-214. PubMed ID: 32289791
[TBL] [Abstract][Full Text] [Related]
14. Precision psychiatry: The complexity of personalizing antipsychotic dosing.
de Leon J
Eur Neuropsychopharmacol; 2022 May; 58():80-85. PubMed ID: 35314415
[TBL] [Abstract][Full Text] [Related]
15. Valproate, obesity and other causes of clozapine poor metabolism in the context of rapid titration may explain clozapine-induced myocarditis: A re-analysis of a Turkish case series.
Ertuğrul A; Anıl Yağcıoğlu AE; Ağaoğlu E; Karakaşlı AA; Ak S; Yazıcı MK; de Leon J
Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(4):281-286. PubMed ID: 36513403
[TBL] [Abstract][Full Text] [Related]
16. European Whites May Need Lower Minimum Therapeutic Clozapine Doses Than Those Customarily Proposed.
Schoretsanitis G; Smith RL; Molden E; Solismaa A; Seppälä N; Kopeček M; Švancer P; Olmos I; Vázquez M; Iglesias-Garcia C; Iglesias-Alonso A; Spina E; de Leon J
J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):140-147. PubMed ID: 33587398
[TBL] [Abstract][Full Text] [Related]
17. Will ChatGPT3 Substitute for us as Clozapine Experts?
de Leon J; De Las Cuevas C
J Clin Psychopharmacol; 2023 Sep-Oct 01; 43(5):400-402. PubMed ID: 37683226
[TBL] [Abstract][Full Text] [Related]
18. [Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports].
Papetti F; Morel-Pingault V; Buisse V; Maziere L; Banayan M; Thauby S; Besnard T; Darcourt G; Pringuey D
Encephale; 2007 Oct; 33(5):811-8. PubMed ID: 18357853
[TBL] [Abstract][Full Text] [Related]
19. Clozapine Metabolism in East Asians and Caucasians: A Pilot Exploration of the Prevalence of Poor Metabolizers and a Systematic Review.
Ruan CJ; Zang YN; Wang CY; Cheng YH; Sun C; Spina E; de Leon J
J Clin Psychopharmacol; 2019; 39(2):135-144. PubMed ID: 30811372
[TBL] [Abstract][Full Text] [Related]
20. The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement.
van der Weide J; Steijns LS; van Weelden MJ
Pharmacogenetics; 2003 Mar; 13(3):169-72. PubMed ID: 12618594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
